Spotlight on the BRICs
Biotechnology innovation is an engine of economic growth. Many countries have thus made the development of a biotechnology sector an economic priority and have allocated significant resources into its development. While the established markets remain a vital source of new discoveries and business opportunities, the emerging markets are becoming increasingly attractive as governments implement national strategies for biotechnology growth and development.
This program will highlight and explore the development strategies of the four BRIC nations. The panels in this program are designed to identify and discuss specific initiatives within each country that are driving the pace of biotechnology innovation. Each nation will have a dedicated half-day program.
Spotlight on China: Biotechnology as a Strategic Priority for National Development: The Chinese Government has identified biotechnology as a strategic priority for national development. During the 2013 BIO International Convention, a half-day of programming has been devoted to exploring the Chinese biotechnology market and the real impact of China’s strategic prioritization of the industry, including the impact of a new generation of Chinese leaders. The program will include a discussion about the implications of China’s current healthcare reform for innovative biologics and the release of a study BIO has produced on Building a World-Class Innovative Therapeutic Biologics Industry in China.
8:30 AM - 9:00 AM - Welcome & Opening Presentation by CFDA Commissioner
9:00 AM - 9:50 AM - CFDA Official Discussion: Key Technical Issues and the CFDA Drug Approval Process
10:00 AM - 10:55 AM - Recent Developments in China's Biomedicine Industry
11:00 AM - 12:00 PM - Building a World-Class Innovative Therapeutic Biologics Industry in China, a BIO RDPAC White Paper
Ability Level: All
Session ID: 2043